OC
BME icon

Oppenheimer & Co’s BlackRock Health Sciences Trust BME Stock Holding History

Oppenheimer & Co’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261K Sell
6,774
-14
-0.2% -$577 ﹤0.01% 1451
2025
Q4 		$279K Buy
6,788
+73
+1% +$2.88K ﹤0.01% 1297
2025
Q3 		$250K Buy
6,715
+373
+6% +$13.6K ﹤0.01% 1458
2025
Q2 		$231K Buy
6,342
+47
+0.7% +$1.7K ﹤0.01% 1447
2025
Q1 		$243K Buy
6,295
+486
+8% +$19.3K ﹤0.01% 1370
2024
Q4 		$220K Sell
5,809
-83
-1% -$3.31K ﹤0.01% 1418
2024
Q3 		$247K Sell
5,892
-30
-0.5% -$1.25K ﹤0.01% 1326
2024
Q2 		$242K Buy
5,922
+67
+1% +$2.67K ﹤0.01% 1270
2024
Q1 		$243K Hold
5,855
– – ﹤0.01% 1261
2023
Q4 		$237K Sell
5,855
-250
-4% -$9.55K ﹤0.01% 1226
2023
Q3 		$239K Sell
6,105
-575
-9% -$22.9K ﹤0.01% 1209
2023
Q2 		$271K Buy
6,680
+409
+7% +$16.8K 0.01% 1197
2023
Q1 		$263K Buy
6,271
+355
+6% +$14.9K 0.01% 1171
2022
Q4 		$258K Buy
+5,916
New +$251K 0.01% 1140
2022
Q1 		– Sell
-5,816
Closed -$282K – 1483
2021
Q4 		$282K Sell
5,816
-290
-5% -$13.7K ﹤0.01% 1256
2021
Q3 		$291K Buy
6,106
+1,426
+30% +$69.5K 0.01% 1239
2021
Q2 		$227K Buy
+4,680
New +$224K ﹤0.01% 1373

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Oppenheimer & Co's BME Position: Q1 2026 in Review

Oppenheimer & Co reduced its BlackRock Health Sciences Trust (BME) stake by 0.21% in Q1 2026, selling an estimated $577 and leaving 6,774 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

Oppenheimer & Co first reported a position in BME in Q2 2021 and has held it in 17 quarters since. The position peaked at $291K in Q3 2021. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Oppenheimer & Co held 6,774 shares of BlackRock Health Sciences Trust worth $261K as of Q1 2026.
  • Oppenheimer & Co sold 14 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $577.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1451 holding.
  • Oppenheimer & Co first reported a position in BlackRock Health Sciences Trust in Q2 2021 and has held it in 17 quarters since.
  • Oppenheimer & Co's BlackRock Health Sciences Trust position peaked at $291K in Q3 2021.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.